Update on yttrium-90-based radio-embolization for treatment of hepatocellular carcinoma (Q38022739)

27 August 2017

title

Update on yttrium-90-based radio-embolization for treatment of hepatocellular carcinoma (English)

1 reference

27 August 2017

Raymond Wai Man Kan

1

1 reference

27 August 2017

Simon Hing Yin Tsang

series ordinal

2

1 reference

27 August 2017

Ronnie Tung Ping Poon

series ordinal

3

1 reference

27 August 2017

Tan To Cheung

series ordinal

4

1 reference

27 August 2017

publication date

3 July 2012

1 reference

27 August 2017

published in

ANZ Journal of Surgery

1 reference

27 August 2017

volume

82

1 reference

27 August 2017

issue

7-8

1 reference

27 August 2017

page(s)

505-509

1 reference

TREATMENT OF INOPERABLE PRIMARY PANCREATIC AND LIVER CANCER BY THE INTRA-ARTERIAL ADMINISTRATION OF RADIOACTIVE ISOTOPES (Y90 RADIATING MICROSPHERES).

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-2197.2012.06121.X

10.1111/J.1445-2197.2012.06121.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference